Jump Financial, LLC Actinium Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$7.15 - $9.39 $25,797 - $33,879	3,608 Added 27.56%	16,700 $123,000
Q2 2023 Aug 07, 2023	BUY	$7.15 - $9.39 $25,797 - $33,879	3,608 Added 27.56%	16,700 $123,000
Q1 2023 Oct 21, 2024	BUY	$8.51 - $14.26 $111,412 - $186,691	13,092 New	13,092 $123,000
Q1 2023 May 03, 2023	SELL	$8.51 - $14.26 $90,384 - $151,455	-10,621 Reduced 44.79%	13,092 $123,000
Q4 2022 Feb 13, 2023	BUY	$7.05 - $14.41 $2,206 - $4,510	313 Added 1.34%	23,713 $252,000
Q3 2022 Nov 07, 2022	BUY	$4.81 - $8.48 $112,553 - $198,432	23,400 New	23,400 $173,000

8.31M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $28.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.